Immunothérapie allergénique chez l’enfant et l’adolescent

Specific allergic immunotherapy requires repeated administration of allergens in order to induce clinical and immunological tolerance. This is the only therapy with an aetiological aim that modifies the course of the disease by ensuring remission after the interruption of the procedure. The preventi...

Descripción completa

Detalles Bibliográficos
Autores principales: Amat, F., Labbé, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2020
Materias:
Revue Générale
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474839/
https://www.ncbi.nlm.nih.gov/pubmed/32922566
http://dx.doi.org/10.1016/j.reval.2020.07.003
_version_ 1783579399389446144
author Amat, F.
Labbé, A.
author_facet Amat, F.
Labbé, A.
author_sort Amat, F.
collection PubMed
description Specific allergic immunotherapy requires repeated administration of allergens in order to induce clinical and immunological tolerance. This is the only therapy with an aetiological aim that modifies the course of the disease by ensuring remission after the interruption of the procedure. The prevention of new sensitizations by immunotherapy is still under discussion. In this review we will consider the main immunological mechanisms and indications for immunotherapy in children and adolescents.
format Online
Article
Text
id pubmed-7474839
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-74748392020-09-08 Immunothérapie allergénique chez l’enfant et l’adolescent Amat, F. Labbé, A. Rev Fr Allergol (2009) Revue Générale Specific allergic immunotherapy requires repeated administration of allergens in order to induce clinical and immunological tolerance. This is the only therapy with an aetiological aim that modifies the course of the disease by ensuring remission after the interruption of the procedure. The prevention of new sensitizations by immunotherapy is still under discussion. In this review we will consider the main immunological mechanisms and indications for immunotherapy in children and adolescents. Elsevier Masson SAS. 2020 2020-09-06 /pmc/articles/PMC7474839/ /pubmed/32922566 http://dx.doi.org/10.1016/j.reval.2020.07.003 Text en © 2020 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Revue Générale
Amat, F.
Labbé, A.
Immunothérapie allergénique chez l’enfant et l’adolescent
title Immunothérapie allergénique chez l’enfant et l’adolescent
title_full Immunothérapie allergénique chez l’enfant et l’adolescent
title_fullStr Immunothérapie allergénique chez l’enfant et l’adolescent
title_full_unstemmed Immunothérapie allergénique chez l’enfant et l’adolescent
title_short Immunothérapie allergénique chez l’enfant et l’adolescent
title_sort immunothérapie allergénique chez l’enfant et l’adolescent
topic Revue Générale
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474839/
https://www.ncbi.nlm.nih.gov/pubmed/32922566
http://dx.doi.org/10.1016/j.reval.2020.07.003
work_keys_str_mv AT amatf immunotherapieallergeniquechezlenfantetladolescent
AT labbea immunotherapieallergeniquechezlenfantetladolescent

Ejemplares similares